The golden oyster mushroom, a tasty species native to Asia, has proliferated in states around the Great Lakes and may crowd out native species, a new study shows.
Physicists working at the CERN particle physics lab said they detected a slight but significant difference in how particles of matter and antimatter decay.
Jensen Huang, the chipmaker’s chief executive, is trying to balance his company’s interests as the United States and China compete for supremacy in artificial intelligence.
Goldman and other investment banks are feeding off a Trump boom.
In polarized Washington, Ama is drawing leaders from both camps with an anti-additive menu and a vow to bar all manner of toxicity.
The JPMorgan Chase chief has long been skeptical of the nontraditional, and less regulated, lending business. Now he thinks its best days may be over.
Details are still scarce on the agreement, which the president said will partly walk back some of the steep tariffs he threatened on the country last week.
Clues from another dry spell 6,000 years ago are helping scientists understand what’s driving the latest one, and why it’s been so unrelenting.
Economists say it will take time for the effects of trade policies to show up in economic data — but acknowledge they aren’t sure how long.
In Chile and Argentina, dramatic slopes, lots of snow and an unusual après ski scene await.
Whey, the liquid byproduct of cheese making, was once considered waste. Now it is a key ingredient in the protein powders that Ozempic users and weight lifters are downing in ever-greater amounts.
Unlike with opioids, there is no medication to suppress cravings for meth and other stimulants. As use soars, hundreds of clinics are trying a radically different approach.
Beijing is taking an industrial policy approach to help its A.I. companies close the gap with those in the United States.
Zohran Mamdani, the Democratic nominee in the race for mayor of New York City, moved to distance himself from comments that sparked outrage during the primary.
The United States has begun investigating Brazil’s trade practices and “anti-corruption interference,” after the president’s criticisms of Brazil’s treatment of Jair Bolsonaro, a Trump ally.
Trump administration officials say winning the artificial intelligence race with China is a top priority.
The site became prominent last year when people bet on the outcome of the 2024 presidential election.
Staff members who were first notified of terminations in April were finally let go late Monday.
Drastic measures are necessary “before we are crushed by the debt,” the country’s prime minister warned.
The C.E.O. of JPMorgan Chase, who has rarely taken on President Trump during his second term, wades into the argument over the Federal Reserve chair.
New data showing price increases last month could foreshadow even higher costs if the president imposes steep tariffs on Aug. 1.
In an about-face, the administration is cracking down on so-called skin substitutes, overused treatments that cost Medicare more than $10 billion last year.
For-profit hospitals provide most inpatient physical therapy but tend to have worse readmission rates to general hospitals. Medicare doesn’t tell consumers about troubling inspections.